Viral mutation rates

Journal of Virology

Volumn 84, Issue 19, 2010, Pages 9733-9748

  Sanjuán, Rafael ^a   Nebot, Miguel R ^b   Chirico, Nicola ^c   Mansky, Louis M ^d   Belshaw, Robert ^e  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIOPHAGE; COMPARATIVE STUDY; DNA VIRUS; GENOME SIZE; INDEL MUTATION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RNA VIRUS; VIRUS INFECTION; VIRUS MUTATION; ANIMAL; BIOLOGICAL MODEL; GENETICS; HUMAN; MOLECULAR EVOLUTION; MUTATION; TIME; VIRUS;

DNA VIRUSES; RNA VIRUSES;

DNA VIRUS;

ANIMALS; DNA VIRUSES; EVOLUTION, MOLECULAR; HUMANS; MODELS, GENETIC; MUTATION; RNA VIRUSES; TIME FACTORS; VIRUSES;

EID: 77956826336     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00694-10     Document Type: Article

References (93)

1. Anderson, J. P., R. Daifuku, and L. A. Loeb. 2004. Viral error catastrophe by mutagenic nucleosides. Annu. Rev. Microbiol. 58:183-205.
2. Batschelet, E., E. Domingo, and C. Weissmann. 1976. The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. Gene 1:27-32.
3. Bebenek, K., J. Abbotts, J. D. Roberts, S. H. Wilson, and T. A. Kunkel. 1989. Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J. Biol. Chem. 264:16948-16956.
4. Belshaw, R., A. Gardner, A. Rambaut, and O. G. Pybus. 2008. Pacing a small cage: mutation and RNA viruses. Trends Ecol. Evol. 23:188-193.
5. Bull, J. J., R. Sanjuán, and C. O. Wilke. 2007. Theory of lethal mutagenesis for viruses. J. Virol. 81:2930-2939.
6. Carrasco, P., F. de la Iglesia, and S. F. Elena. 2007. Distribution of fitness and virulence effects caused by single-nucleotide substitutions in tobacco etch virus. J. Virol. 81:12979-12984.
7. Carter, J., and V. Saunders. 2007. Virology: principles and applications. Wiley, New York, NY.
8. Challberg, M. D., and T. J. Kelly. 1989. Animal virus DNA replication. Annu. Rev. Biochem. 58:671-717.
9. Chao, L., C. U. Rang, and L. E. Wong. 2002. Distribution of spontaneous mutants and inferences about the replication mode of the RNA bacteriophage φ6. J. Virol. 76:3276-3281.
10. Chung, D. H., Y. Sun, W. B. Parker, J. B. Arterburn, A. Bartolucci, and C. B. Jonsson. 2007. Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus. J. Virol. 81:11722-11729.
11. Crotty, S., C. E. Cameron, and R. Andino. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U. S. A. 98:6895-6900.
12. Cuevas, J. M., S. Duffy, and R. Sanjuán. 2009. Point mutation rate of bacteriophage ΦX174. Genetics 183:747-749.
13. Cuevas, J. M., F. González-Candelas, A. Moya, and R. Sanjuán. 2009. The effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo. J. Virol. 83:5760-5764.
14. Cuevas, J. M., A. Moya, and R. Sanjuán. 2005. Following the very initial growth of biological RNA viral clones. J. Gen. Virol. 86:435-443.
15. Dapp, M. J., C. L. Clouser, S. Patterson, and L. M. Mansky. 2009. 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. J. Virol. 83:11950-11958.
16. Davenport, M. P., L. Loh, J. Petravic, and S. J. Kent. 2008. Rates of HIV immune escape and reversion: implications for vaccination. Trends Microbiol. 16:561-566.
17. de la Torre, J. C., C. Giachetti, B. L. Semler, and J. J. Holland. 1992. High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc. Natl. Acad. Sci. U. S. A. 89:2531-2535.
18. de la Torre, J. C., E. Wimmer, and J. J. Holland. 1990. Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus. J. Virol. 64:664-671.
19. Denhardt, D. T., and R. B. Silver. 1966. An analysis of the clone size distribution of ΦX174 mutants and recombinants. Virology 30:10-19.
20. De Paepe, M., and F. Taddei. 2006. Viruses' life history: towards a mechanistic basis of a trade-off between survival and reproduction among phages. PLoS Biol. 4:e193.
21. Domingo, E. 2006. Quasispecies: concept and implications for virology. Springer, New York, NY.
22. Domingo, E., R. A. Flavell, and C. Weissmann. 1976. In vitro site-directed mutagenesis: generation and properties of an infectious extracistronic mutant of bacteriophage Qβ. Gene 1:3-25.
23. Domingo-Calap, P., J. M. Cuevas, and R. Sanjuán. 2009. The fitness effects of random mutations in single-stranded DNA and RNA bacteriophages. PLoS Genet. 5:e1000742.
24. Dougherty, J. P., and H. M. Temin. 1988. Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J. Virol. 62:2817-2822.
25. Dove, W. F. 1968. The genetics of the lambdoid phages. Annu. Rev. Genet. 2:305-340.
26. Drake, J. W. 1991. A constant rate of spontaneous mutation in DNA-based microbes. Proc. Natl. Acad. Sci. U. S. A. 88:7160-7164.
27. Drake, J. W. 1993. Rates of spontaneous mutation among RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 90:4171-4175.
28. Drake, J. W. 2009. Avoiding dangerous missense: thermophiles display especially low mutation rates. PLoS Genet. 5:e1000520.
29. Drake, J. W., B. Charlesworth, D. Charlesworth, and J. F. Crow. 1998. Rates of spontaneous mutation. Genetics 148:1667-1686.
30. Drake, J. W., and J. J. Holland. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 96:13910-13913.
31. Drake, J. W., and C. B. Hwang. 2005. On the mutation rate of herpes simplex virus type 1. Genetics 170:969-970.
32. Duffy, S., L. A. Shackelton, and E. C. Holmes. 2008. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 9:267-276.
33. Durán-Vila, R., S. F. Elena, J. A. Daròs, and R. Flores. 2008. Structure and evolution of viroids, p. 43-64. In E. Domingo, C. R. Parrish, and J. J. Holland (ed.), Origin and evolution of viruses. Elsevier, New York, NY.
34. Eckerle, L. D., X. Lu, S. M. Sperry, L. Choi, and M. R. Denison. 2007. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J. Virol. 81:12135-12144.
35. Flores, R., C. Hernández, A. E. Martínez de Alba, J. A. Daròs, and F. Di Serio. 2005. Viroids and viroid-host interactions. Annu. Rev. Phytopathol. 43:117-139.
36. Furió, V., A. Moya, and R. Sanjuán. 2005. The cost of replication fidelity in an RNA virus. Proc. Natl. Acad. Sci. U. S. A. 102:10233-10237.
37. Gago, S., S. F. Elena, R. Flores, and R. Sanjuán. 2009. Extremely high mutation rate of a hammerhead viroid. Science 323:1308.
38. Gao, F., Y. Chen, D. N. Levy, J. A. Conway, T. B. Kepler, and H. Hui. 2004. Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J. Virol. 78:2426-2433.
39. Graci, J. D., D. A. Harki, V. S. Korneeva, J. P. Edathil, K. Too, D. Franco, E. D. Smidansky, A. V. Paul, B. R. Peterson, D. M. Brown, D. Loakes, and C. E. Cameron. 2007. Lethal mutagenesis of poliovirus mediated by a mutagenic pyrimidine analogue. J. Virol. 81:11256-11266.
40. Grande-Pérez, A., E. Lázaro, P. Lowenstein, E. Domingo, and S. C. Manrubia. 2005. Suppression of viral infectivity through lethal defection. Proc. Natl. Acad. Sci. U. S. A. 102:4448-4452.
41. Heinz, B. A., R. R. Rueckert, D. A. Shepard, F. J. Dutko, M. A. McKinlay, M. Fancher, M. G. Rossmann, J. Badger, and T. J. Smith. 1989. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J. Virol. 63:2476-2485.
42. Hirano, N., K. Fujiwara, and M. Matumoto. 1976. Mouse hepatitis virus (MHV-2). Plaque assay and propagation in mouse cell line DBT cells. Jpn. J. Microbiol. 20:219-225.
43. Holland, J. J., J. C. de la Torre, D. A. Steinhauer, D. K. Clarke, E. A. Duarte, and E. Domingo. 1989. Virus mutation frequencies can be greatly underestimated by monoclonal antibody neutralization of virions. J. Virol. 63:5030-5036.
44. Holland, J. J., E. Domingo, J. C. de la Torre, and D. A. Steinhauer. 1990. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 64:3960-3962.
45. Holland, J. J., K. Spindler, F. Horodyski, E. Grabau, S. Nichol, and S. VandePol. 1982. Rapid evolution of RNA genomes. Science 215:1577-1585.
46. Holmes, E. C. 2009. The evolution and emergence of RNA viruses. Oxford University Press, Oxford, United Kingdom.
47. Huang, K. J., and D. P. Wooley. 2005. A new cell-based assay for measuring the forward mutation rate of HIV-1. J. Virol. Methods 124:95-104.
48. Jenkins, G. M., A. Rambaut, O. G. Pybus, and E. C. Holmes. 2002. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J. Mol. Evol. 54:156-165.
49. Kunkel, T. A. 1985. The mutational specificity of DNA polymerase-beta during in vitro DNA synthesis. Production of frameshift, base substitution, and deletion mutations. J. Biol. Chem. 260:5787-5796.
50. Kunkel, T. A. 2004. DNA replication fidelity. J. Biol. Chem. 279:16895-16898.
51. Laakso, M. M., and R. E. Sutton. 2006. Replicative fidelity of lentiviral vectors produced by transient transfection. Virology 348:406-417.
52. Leider, J. M., P. Palese, and F. I. Smith. 1988. Determination of the mutation rate of a retrovirus. J. Virol. 62:3084-3091.
53. Loeb, L. A., J. M. Essigmann, F. Kazazi, J. Zhang, K. D. Rose, and J. I. Mullins. 1999. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc. Natl. Acad. Sci. U. S. A. 96:1492-1497.
54. Lu, Q., Y. T. Hwang, and C. B. Hwang. 2002. Mutation spectra of herpes simplex virus type 1 thymidine kinase mutants. J. Virol. 76:5822-5828.
55. Luria, S. E. 1951. The frequency distribution of spontaneous bacteriophage mutants as evidence for the exponential rate of phage reproduction. Cold Spring Harbor Symp. Quant. Biol. 16:463-470.
56. Luria, S. E., and M. Delbrück. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.
57. Lynch, M. 2006. The origins of eukaryotic gene structure. Mol. Biol. Evol. 23:450-468.
58. Malpica, J. M., A. Fraile, I. Moreno, C. I. Obies, J. W. Drake, and F. García-Arenal. 2002. The rate and character of spontaneous mutation in an RNA virus. Genetics 162:1505-1511.
59. Mansky, L. M. 1998. Retrovirus mutation rates and their role in genetic variation. J. Gen. Virol. 79:1337-1345.
60. Mansky, L. M. 2000. In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy. J. Virol. 74:9525-9531.
61. Mansky, L. M., and L. C. Bernard. 2000. 3-Azido-3-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1. J. Virol. 74:9532-9539.
62. Mansky, L. M., S. Preveral, L. Selig, R. Benarous, and S. Benichou. 2000. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J. Virol. 74:7039-7047.
63. Mansky, L. M., and H. M. Temin. 1994. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J. Virol. 68:494-499.
64. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
65. Minskaia, E., T. Hertzig, A. E. Gorbalenya, V. Campanacci, C. Cambillau, B. Canard, and J. Ziebuhr. 2006. Discovery of an RNA virus 3′→ 5′ exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc. Natl. Acad. Sci. U. S. A. 103:5108-5113.
66. Monk, R. J., F. G. Malik, D. Stokesberry, and L. H. Evans. 1992. Direct determination of the point mutation rate of a murine retrovirus. J. Virol. 66:3683-3689.
67. Niwa, O., A. Decleve, M. Liberman, and H. S. Kaplan. 1973. Adaptation of plaque assay methods to the in vitro quantitation of the radiation leukemia virus. J. Virol. 12:68-73.
68. Nobusawa, E., and K. Sato. 2006. Comparison of the mutation rates of human influenza A and B viruses. J. Virol. 80:3675-3678.
69. Parthasarathi, S., A. Varela-Echavarría, Y. Ron, B. D. Preston, and J. P. Dougherty. 1995. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J. Virol. 69:7991-8000.
70. Parvin, J. D., A. Moscona, W. T. Pan, J. M. Leider, and P. Palese. 1986. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J. Virol. 59:377-383.
71. Pathak, V. K., and H. M. Temin. 1990. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc. Natl. Acad. Sci. U. S. A. 87:6019-6023.
72. Perelson, A. S. 2002. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2:28-36.
73. Peris, J. B., P. Davis, J. M. Cuevas, M. R. Nebot, and R. Sanjuán. 2010. Distribution of fitness effects caused by single-nucleotide substitutions in bacteriophage f1. Genetics 185:603-609.
74. Pfeiffer, J. K., and K. Kirkegaard. 2003. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl. Acad. Sci. U. S. A. 100:7289-7294.
75. Pfeiffer, J. K., and K. Kirkegaard. 2005. Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog. 1:e11.
76. Pult, I., N. Abbott, Y. Y. Zhang, and J. Summers. 2001. Frequency of spontaneous mutations in an avian hepadnavirus infection. J. Virol. 75:9623-9632. (Pubitemid 32900097)
77. Raney, J. L., R. R. Delongchamp, and C. R. Valentine. 2004. Spontaneous mutant frequency and mutation spectrum for gene A of ΦX174 grown in E. coli. Environ. Mol. Mutagen. 44:119-127.
78. Sanjuán, R. 2010. Mutational fitness effects in RNA and ssDNA viruses: common patterns revealed by site-directed mutagenesis studies. Philos. Trans. R. Soc. Lond. 365:1975-1982.
79. Sanjuán, R., P. Agudelo-Romero, and S. F. Elena. 2009. Upper-limit mutation rate estimation for a plant RNA virus. Biol. Lett. 5:394-396.
80. Sanjuán, R., A. Moya, and S. F. Elena. 2004. The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc. Natl. Acad. Sci. U. S. A. 101:8396-8401.
81. Schrag, S. J., P. A. Rota, and W. J. Bellini. 1999. Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J. Virol. 73:51-54.
82. Sedivy, J. M., J. P. Capone, U. L. RajBhandary, and P. A. Sharp. 1987. An inducible mammalian amber suppressor: propagation of a poliovirus mutant. Cell 50:379-389.
83. Sierra, S., M. Dávila, P. R. Lowenstein, and E. Domingo. 2000. Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J. Virol. 74:8316-8323.
84. Stech, J., X. Xiong, C. Scholtissek, and R. G. Webster. 1999. Independence of evolutionary and mutational rates after transmission of avian influenza viruses to swine. J. Virol. 73:1878-1884.
85. Suárez, P., J. Valcárcel, and J. Ortín. 1992. Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants. J. Virol. 66:2491-2494.
86. Suárez-López, P., and J. Ortín. 1994. An estimation of the nucleotide substitution rate at defined positions in the influenza virus haemagglutinin gene. J. Gen. Virol. 75:389-393.
87. Thomas, M. J., A. A. Platas, and D. K. Hawley. 1998. Transcriptional fidelity and proofreading by RNA polymerase II. Cell 93:627-637.
88. Tromas, N., and S. F. Elena. 2010. The rate and spectrum of spontaneous mutations in a plant RNA virus. Genetics 185:983-989.
89. Varela-Echavarría, A., N. Garvey, B. D. Preston, and J. P. Dougherty. 1992. Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase in vitro. J. Biol. Chem. 267:24681-24688.
90. Vignuzzi, M., J. K. Stone, J. J. Arnold, C. E. Cameron, and R. Andino. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344-348.
91. Vignuzzi, M., E. Wendt, and R. Andino. 2008. Engineering attenuated virus vaccines by controlling replication fidelity. Nat. Med. 14:154-161.
92. Wain-Hobson, S. 1993. The fastest genome evolution ever described: HIV variation in situ. Curr. Opin. Genet. Dev. 3:878-883.
93. Wang, W., W. M. Lee, A. G. Mosser, and R. R. Rueckert. 1998. WIN 52035-dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface. J. Virol. 72:1210-1218.